Molecular Devices cut by Thomas Weisel

Molecular Devices Corp. was downgraded by Thomas Weisel Partners to peer perform from outperform. The Sunnyvale, Calif., firm designs and makes bioanalytical measurement systems for drug discovery and other life sciences research. Molecular Devices shares on Thursday lost 20 cents, or 0.97%, to close at $20.48 on volume of 171,397 shares versus the three-month running average of 193,922.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.